Using Binary Actuation Technology (BAT), IMOD® is the only responsive oxygen delivery device able to monitor and automatically adjust to a patient’s individual oxygen needs and requirements.
IMOD® receives oxygen from a bottled or bulk supply and reactively delivers the correct dose through a nasal cannula or a face mask, the first in its class to do so. The ultra-sensitive breath-detection system at the heart of IMOD®, enabled by BAT, tracks the user’s breathing pattern and delivers oxygen even with the slightest inhalation.
Discover the features and benefits of IMOD®
Oxygen therapy is required for a broad range of respiratory and non-respiratory diseases such as anaemia, lung cancer, anaphylaxis, post-surgery while the patient is recovering from anaesthesia and emergency medicine. Only 69% of patients using emergency oxygen maintain a saturation within the intended prescribed range.1
Respiratory Consultants from Royal Derby hospital estimate 2000 to 4000 patients a year in the UK are “killed unnecessarily by incorrect oxygen supply”.2 Developed in collaboration with leading clinicians, the IMOD® system offers significant clinical benefits while dramatically improving patient experience and reducing the consumption of medical oxygen by two thirds.
Quality of Life Benefits
Improved quality of life and superior patient comfort.3,4
Delivers oxygen to maintain a prescribed oxygen saturation
Supplies oxygen only during inhalation, which means that oxygen bottles last three times as long
Follows changes in breathing rate
The only oxygen conserving device to work with either a facemask in addition to a nasal cannula, improving patient comfort
Operates from piped supply or bottles, therefore versatile
Has extensive safety features
Has up to 40 hours battery life
Immediate clinical benefit through prevention
of over-consumption and optimum blood oxygen concentration.4,5
Accurate and diverse monitoring capabilities
Breath synchronised mode
IMOD® can deliver up to 15 litres of oxygen per minute
Significant cost savings through reduction of waste and increased efficiency. 5
Expected oxygen saving of up to 66% compared to continuous supply, allowing oxygen bottles to last up to three times as long. 5
A 1,000-bed hospital could potentially save up to £200,000 per annum on wasted oxygen – up to two-thirds of current expenditure. 5
References: 1. British Thoracic Society Emergency Oxygen Audit Report National Audit Period. Ronan O’Driscoll. 15 August – 1 November 2015 https://www.brit-thoracic.org.uk/document-library/audit-and-quality-improvement/audit-reports/bts-emergency-oxygen-audit-report-2015/ . 2. Data on file – IMOS: Expert medical Reactions. Received September 2017. 3. Camcon Medical Ltd – IMOS – User manual (prepared by EG technology). 25 September 2017. 4. Camcon Medical Ltd – IMOS – Performance overview (prepared by EG technology). 25 September 2017. 5. IMOS Device: Clinical Insight and Technical Validation Report. Cambridge University Hospitals NHS. June 2014.